Cargando…
Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659710/ https://www.ncbi.nlm.nih.gov/pubmed/38026788 http://dx.doi.org/10.1097/HS9.0000000000000983 |
_version_ | 1785148369997398016 |
---|---|
author | Gopalakrishnan, Sathej Menon, Rajeev Suleiman, Ahmed A. Kater, Arnon P. Stilgenbauer, Stephan Seymour, John F. Chyla, Brenda Lu, Tong Young Kim, Su Roberts, Andrew W. Woyach, Jennifer A. Mensing, Sven Salem, Ahmed Hamed |
author_facet | Gopalakrishnan, Sathej Menon, Rajeev Suleiman, Ahmed A. Kater, Arnon P. Stilgenbauer, Stephan Seymour, John F. Chyla, Brenda Lu, Tong Young Kim, Su Roberts, Andrew W. Woyach, Jennifer A. Mensing, Sven Salem, Ahmed Hamed |
author_sort | Gopalakrishnan, Sathej |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10659710 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-106597102023-11-17 Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies Gopalakrishnan, Sathej Menon, Rajeev Suleiman, Ahmed A. Kater, Arnon P. Stilgenbauer, Stephan Seymour, John F. Chyla, Brenda Lu, Tong Young Kim, Su Roberts, Andrew W. Woyach, Jennifer A. Mensing, Sven Salem, Ahmed Hamed Hemasphere Letter Lippincott Williams & Wilkins 2023-11-17 /pmc/articles/PMC10659710/ /pubmed/38026788 http://dx.doi.org/10.1097/HS9.0000000000000983 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Letter Gopalakrishnan, Sathej Menon, Rajeev Suleiman, Ahmed A. Kater, Arnon P. Stilgenbauer, Stephan Seymour, John F. Chyla, Brenda Lu, Tong Young Kim, Su Roberts, Andrew W. Woyach, Jennifer A. Mensing, Sven Salem, Ahmed Hamed Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies |
title | Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies |
title_full | Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies |
title_fullStr | Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies |
title_full_unstemmed | Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies |
title_short | Relationship Between Venetoclax Exposure and Undetectable Minimal Residual Disease Rates in Relapsed/Refractory Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of Six Clinical Studies |
title_sort | relationship between venetoclax exposure and undetectable minimal residual disease rates in relapsed/refractory patients with chronic lymphocytic leukemia: a pooled analysis of six clinical studies |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659710/ https://www.ncbi.nlm.nih.gov/pubmed/38026788 http://dx.doi.org/10.1097/HS9.0000000000000983 |
work_keys_str_mv | AT gopalakrishnansathej relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT menonrajeev relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT suleimanahmeda relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT katerarnonp relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT stilgenbauerstephan relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT seymourjohnf relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT chylabrenda relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT lutong relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT youngkimsu relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT robertsandreww relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT woyachjennifera relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT mensingsven relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies AT salemahmedhamed relationshipbetweenvenetoclaxexposureandundetectableminimalresidualdiseaseratesinrelapsedrefractorypatientswithchroniclymphocyticleukemiaapooledanalysisofsixclinicalstudies |